Tratamiento del carcinoma basocelular en el anciano

REFERENCIAS

1. Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol. 2006;19(Suppl 2):S127-S147.

2. Goldsmith LA, Fitzpatrick TB. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: McGraw-Hill Medical; 2012.

3. Rogers HW, Coldiron BM. Analysis of skin cancer treatment and costs in the United States Medicare population, 1996-2008. Dermatol Surg. 2013;39:35-42.

4. Baxter JM, Patel AN, Varma S. Facial basal cell carcinoma. BMJ. 2012;345:e5342.

5. Mohan SV, Chang AL. Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep. 2014;3:40-45.

6. Draft Recommendation Statement: Skin Cancer: Screening. U.S. Preventive Services Task Force. November 2015. Available at: http://www.

uspreventiveservicestaskforce.org/Page/Document/draft-recommendationstatement168/

skin-cancer-screening. Accessed November 30, 2015.

7. Centers for Disease Control and Prevention. Trends in agingeUnited States and worldwide. MMWR Morb Mortal Wkly Rep. 2003;52:101-104, 106.

8. Mathers CD, Stevens GA, Boerma T, White RA, Tobias MI. Causes of international increases in older age life expectancy. Lancet. 2015;385:540-548.

9. Linos E, Schroeder SA, Chren MM. Potential overdiagnosis of basalcell carcinoma in older patients with limited life expectancy. JAMA. 2014;312:997-998.

10. Linos E, Parvataneni R, Stuart SE, Boscardin WJ, Landefeld CS, Chren MM. Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. JAMA Intern Med. 2013;173:1006-1012.

11. Randle HW. Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Surg. 1996;22:255-261.

12. Wiznia LE, Shanley KM, Federman DG. Advanced, neglected basal cell carcinoma. South Med J. 2014;107:242-245.

13. Saadoun D, Resche Rigon M, Pol S, et al. PegIFNa/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis. J Hepatol. 2015;62:24-30.

14. von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984;10:1043-1060.

15. Lewin JM, Carrucci JA. Management of aggressive basal cell carcinoma. Curr Derm Rep. 2015;4:213-220.

16. Salasche SJ, Amonette RA. Morpheaform basal-cell epitheliomas. A study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol. 1981;7:387-394.

17. Lee KC, Higgins HW, Lajevardi N, Cruz AP, Dufresne RG Jr. Characteristics of squamous cell carcinoma in situ of the ear treated using mohs micrographic surgery. Dermatol Surg. 2012;38:1951-1955.

18. Connolly AH, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS 2012 Appropriate Use Criteria for Mohs Micrographic Surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Dermatol Surg. 2012;38:1582-1603.